NCT06965114 2026-03-18
Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia
National Cancer Institute (NCI)
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05465174 2026-03-09
PNOC029
University of California, San Francisco
Phase 2 Recruiting
NCT05566795 2026-03-02
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
Day One Biopharmaceuticals, Inc.
Phase 3 Recruiting
NCT04775485 2025-04-10
FIREFLY-1
Day One Biopharmaceuticals, Inc.
Phase 2 Recruiting